Posted 10/5/2023, 2:32:00 AM
FDA authorizes Novavax COVID-19 vaccine, offering new protein-based option for unvaccinated
- FDA authorizes Novavax's COVID-19 vaccine, providing a 3rd vaccine option besides Moderna and Pfizer
- Novavax vaccine uses different protein-based technology than mRNA vaccines
- Novavax vaccine targets latest Omicron variants
- Will be available for ages 12+ who haven't gotten other COVID vaccines, with 1 or 2 doses depending on vaccination status
- Rollout comes 3 weeks after Moderna and Pfizer vaccines amid rise in cases starting in summer 2022
